This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/31/2022
Good day, ladies and gentlemen, and welcome to the Blondertongue Laboratories' fourth quarter and full year 2021 earnings call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Ted Grau. Sir, the floor is yours.
Thank you very much. Hi. Good morning, everyone, and thank you for joining us and participating in Blondertongue Laboratories 2021. fourth quarter and four-year earnings call. I'm Ted Grau, President and Chief Executive Officer of the company. As we give our remarks this morning, we will be discussing certain subjects that will contain forward-looking statements, including management's view of our prospects and evolving trends in the market. As you know, the future is all but impossible to predict, and so I caution you that actual results may differ materially from those that may be projected in our comments. We would ask you to refer to our prior SEC filings, including our Form 10-K for years 2019 and 2020, and our filed Form 10-Qs for the first three quarters of 2020 and for the first three quarters of 2021, as well as our upcoming 10-K for the year ended December 31st, 2021, which also includes information about our Q4 2020 results and 2021 results. Each of those filings include additional information concerning factors that could cause actual results to differ from information discussed this morning. With me today are Stephen Shea, our Chairman of the Board of Launder Tongue Laboratories, and Eric Skolnick, our Chief Financial Officer and Senior Vice President. Eric's remarks will follow mine and will cover our detailed financial results. All of us will be available to answer questions that you may have during a Q&A session immediately following our prepared remarks. For our 2021 full-year results, the company is able to announce a small but positive net income of $84,000, compared with a net loss of $7.47 million for the full year of 2020. The change in year-on-year performance came from a combination of our continued work and progress on operating efficiencies, an improved higher technology product mix that improved our blended product gross margins, and the recognition of significant non-operating income in 2021. The sources of our non-operating income were from the company's qualification for the federal ERTC program in 2021 and the forgiveness of our 2020 Paycheck Protection Program loan that occurred in mid-2021. As discussed on previous quarterly earnings calls, both the federal ERTC and PPP programs were associated with pandemic relief. Our improved product mix yielded a blended gross margin, excuse me, a blended product gross margin improvement in 2021 of 39.8% versus 30% in 2020. And our continued operating efficiency work has yielded a 23% reduction over the last two years when comparing January 2020 versus January 2022 monthly operating expenses. In the fourth quarter of 2021, the company experienced product delivery challenges caused by semiconductor supply chain shortages, with delays, price increases, and batch size uncertainties growing throughout the quarter. Our 2021 fourth quarter sales decreased by 7.7% to $3.993 million from $4.327 million in the fourth quarter of 2020. And our net loss for the fourth quarter was $927,000, compared with a net loss of $2.413 million in the same quarter for 2020. Although the quarter was a relative improvement year on year, it was not in line with our average performance during the first three quarters of last year. In particular, the company had to engage in a series of price increases in an effort to compensate for a very fast-moving environment of rising raw materials costs throughout the quarter. Conversely, the company saw a continued positive movement in product demand in our more advanced technology products, and that had begun during the third quarter of 2021 and was discussed in our third quarter earnings call. Those included demand for our NXG IP video processing products, our Clearview encoder and transcoder product lines, and our AirCaster professional off-air receiver product. This pickup in market demand ultimately led to a year-ending product backlog of approximately $10.2 million on December 31st. On the product front, the company completed and released into production a total of 14 new products and product derivatives during the full year of 2021. We've most recently announced our TiVo-specific NXG platform configuration and our TiVo Hospitality Market Sales Partnership as well as Blonderton Laboratory selection and product certification by DIRECTV for our Clearview 4-2 IP video transcoder product line. That announcement also includes our Clearview 4-2 high definition, our standard definition products, as well as our 24-channel and 12-channel versions of those products, as well as those products also being qualified for DIRECTV's equipment subsidy program that they have for their dealers. As the company is entering 2022, we have continued to see improving market demand in a number of areas. So far, that has been an improving hospitality sector, increased demand for our high-speed data products, and a continued positive trend in demand for our latest, most modern, and highest technology video processing, encoding, and transcoding NXG and Clearview product lines. Our biggest challenges have continued from the fourth quarter into early 2022. And at this time, supply chain issues are expected to be the primary driver of uncertainty in our 2022 financial performance. Now, I would like to pass things over to Eric Skolnick, our Chief Financial Officer, to cover our detailed financial results. Eric?
Thanks, Ted. Our net sales decreased $334,000, or 7.7%, to $3,993,000 for the fourth quarter of 2021. from $4,327,000 for the comparable period in 20. The net loss for the three months ended December 31st, 2021 was a loss of $927,000 or a 7 cent loss per share compared to a loss of $2,413,000 or a 23 cent loss per share for the comparable period in 2020. The decrease in sales is primarily attributable to a decrease in sales of CPE products, DOCSIS data products, analog modulation products, and coax distribution products, offset in part by an increase in IP video encoder-transcoder products and our next-gen IP video signal processing series of products. Sales of CPE products were $23,000 and $1,114,000. DOCSIS data products were $122,000 and $418,000. Analog modulation products were $133,000 and 438,000. Coax distribution products were 171,000 and 287,000. Video encoder-transcoder products were 2,529,000 and 1,381,000. And our next-gen series products were 614,000 and 135,000 in the fourth quarter of 2021 and 2020, respectively. For the year ended December 31st, 2021, our net sales decreased $625,000 or 3.8% to $15,754,000 in 2021 from $16,379,000 in 2020. Our net earnings for the 12 months ended December 31st, 2021 were $84,000 or a 2 cents per share, diluted share, excuse me, compared to a net loss of $7,474,000, or a loss of 76 cents per share for the comparable period in 2020. The decrease in sales is primarily attributable to a decrease in sales of CPE products, DOCSIS data products, analog modulation products, and coax distribution products, offset in part by an increase in IP video encoder transcoder products and next-gen IP video signal processing products. Sales of CPE products were $1,120,000 and $4,165,000. DOCSIS data products were $755,000 and $2,184,000. Analog modulation products were $790,000 and $1,274,000. Coax distribution products were $1,266,000 and $1,603,000. Video encoder transcoder products were $7,863,000 and $4,000,000. $245,000, and our next-gen series products were $1,924,705 in 2021 and 2020, respectively. The company experienced a reduction in CPE products during 2021 due to the de-emphasis of this product line, which the company expects to continue into 2022. The company experienced a reduction in DOCSIS data products due to reduced demand caused by the pandemic on these products that are used in the hospitality and assisted living environments. The company expects sales of these products to improve during 2022. The company experienced a reduction in analog modulation products due to the continued market shift away from analog modulation solutions. The company experienced a reduction in coax distribution products due to the reduced demand for legacy products. The company expects the sales of analog modulation and coax distribution products to continue to decline in 2022. The company experienced an increase in video encoder transcoder products and next-gen products, as these product lines represent newer products with advanced technologies and higher demand from customers. the company expects sales of these product lines to remain at 2021 levels or increase in 2022, depending on conditions in the semiconductor supply chain. Although the company does not expect overall sales to return to pre-pandemic levels during 2022, the company does expect overall sales to be higher during 2022 due to approximately $10,240,000 of sales backlog at December 31, 2021. The company's primary sources of liquidity have been its existing cash balances, cash generated from operations, amounts available under our mid-cap business credit LLC revolving credit facility, which is the mid-cap facility, amounts available under a subordinated loan facility, and cash generated from sales of our common stock, as well as funds made available to the company through participation and several federally funded funded financial assistance programs implemented pursuant to the Coronavirus Aid, Relief, and Economic Security Act, including the Paycheck Protection Program and the Employee Retention Tax Credit. On a go-forward basis, the company expects its primary sources of liquidity will be its existing cash balances, cash generated from operations, and amounts available under the MidCap facility. The company also may seek to raise additional capital through the issuance of shares of common stock or other securities convertible into or exercisable for shares of common stock, although the company cannot provide any assurances that this type of additional financing will be available on reasonable terms at all. During 2021, the company received approximately $700,000 under the subordinated loan facility and approximately $492,000 in net proceeds from sales of common stock. Our ability to continue as a going concern is dependent upon our becoming profitable in the future and having access to sufficient capital to execute our business plan and to meet our payment obligations on our debt financing agreements and other financial obligations when they come due. The company had approximately $92,000 and approximately $609,000 available for borrowing under the mid-cap facility as of December 31, 2021 and 2020, respectively. The company's annual report on Form 10-K, which is being filed today, includes an explanatory paragraph going concern from its independent registered public accounting firm. Although the company has actively taken steps to address operating expenses and liquidity, there could be no assurances that these actions and others that the company intends to take in the future will be sufficient to address the concerns relating to the explanatory paragraph going concern. Now I'd like to turn the call over to the question and answer session.
You're reading a preview of the BDR Q4 2021 earnings call.
Free account.
